Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1314893

AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

Description:
AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company that carries out the design, development, production and commercialization of a wide range of primary care and specialty care medicines. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. It offers prescription medicines for treating cardiovascular, metabolic, respiratory, cancer, inflammation, autoimmune, infection and neuroscience diseases. AstraZeneca sells its products through wholly-owned local marketing companies as well as through distributors and local representative offices. The company markets its products principally to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in London, the UK.

AstraZeneca Plc Key Recent Developments

Mar 03, 2016: AstraZeneca patient assistance programs provided hundreds of millions of dollars of support in 2015 to help patients afford medicines
Feb 16, 2016: Data analysis platform driving preclinical modelling capabilities in AstraZeneca launched to wider pharmaceutical industry
Feb 08, 2016: RHINOCORT Allergy Spray Now Available Over the Counter Nationally
Feb 04, 2016: Full-Year and Q4 2015 Results
Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 
Contents:
List of Tables

List of Figures

Section 1 - About the Company

AstraZeneca Plc - Key Facts

AstraZeneca Plc - Key Employees

AstraZeneca Plc - Key Employee Biographies

AstraZeneca Plc - Major Products and Services

AstraZeneca Plc - Pharmaceutical Pipeline Products Data

AstraZeneca Plc, Pipeline Products by Therapy Area

AstraZeneca Plc, Pipeline Products by Development Phase

AstraZeneca Plc - History

AstraZeneca Plc - Company Statement

AstraZeneca Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

AstraZeneca Plc - Key Manufacturing Facilities

Joint Venture

Section 2 – Company Analysis

AstraZeneca Plc - Business Description

AstraZeneca Plc - Corporate Strategy

AstraZeneca Plc - SWOT Analysis

SWOT Analysis - Overview

AstraZeneca Plc - Strengths

Strength - Strong Presence in CVMD Market

Strength - Focused Research and Development Capabilities

Strength - Leading Position

AstraZeneca Plc - Weaknesses

Weakness - Patent Infringements and Other Disputes

Weakness - Product Discontinuations

Weakness - Product Safety Concerns

AstraZeneca Plc - Opportunities

Opportunity - Product Launches and Approvals

Opportunity - Product Pipeline

Opportunity - Orphan Drug Designation

Opportunity - Business Initiatives

AstraZeneca Plc - Threats

Threat - Competitive Pressures from Generic Manufacturers

Threat - Reliance on Third Parties

Threat - Loss of Market Exclusivity

AstraZeneca Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

AstraZeneca Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Mar 03, 2016: AstraZeneca patient assistance programs provided hundreds of millions of dollars of support in 2015 to help patients afford medicines

Feb 16, 2016: Data analysis platform driving preclinical modelling capabilities in AstraZeneca launched to wider pharmaceutical industry

Feb 08, 2016: RHINOCORT Allergy Spray Now Available Over the Counter Nationally

Feb 04, 2016: Full-Year and Q4 2015 Results

Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results

Feb 04, 2016: AstraZeneca Announces Full-Year and Q4 2015 Results

Dec 16, 2015: AstraZeneca continues strategic investment in China to accelerate delivery of innovative biologics and targeted medicines

Dec 15, 2015: Controlling the ‘Social Life’ of Proteins Aims to Transform Drug Discovery

Dec 14, 2015: AZ Investment Gives Local Economy Early Christmas Present

Nov 20, 2015: AstraZeneca and Sanofi exchange over 200,000 chemical compounds

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

AstraZeneca Plc, Key Facts

AstraZeneca Plc, Key Employees

AstraZeneca Plc, Key Employee Biographies

AstraZeneca Plc, Major Products and Services

AstraZeneca Plc, Number of Pipeline Products by Therapy Area

AstraZeneca Plc, Number of Pipeline Products by Development Stage

AstraZeneca Plc, Pipeline Products By Therapy Area and Development Phase

AstraZeneca Plc, History

AstraZeneca Plc, Subsidiaries

AstraZeneca Plc, Key Manufacturing Facilities

AstraZeneca Plc, Joint Venture

AstraZeneca Plc, Key Competitors

AstraZeneca Plc, Ratios based on current share price

AstraZeneca Plc, Annual Ratios

AstraZeneca Plc, Interim Ratios

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

AstraZeneca Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

AstraZeneca Plc, Pipeline Products by Therapy Area

AstraZeneca Plc, Pipeline Products by Development Phase

AstraZeneca Plc, Performance Chart (2011 - 2015)

AstraZeneca Plc, Ratio Charts

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
 
Companies Mentioned
Meda AB
Acadia Pharmaceuticals Inc.
Sucampo Pharmaceuticals, Inc.
Tesaro, Inc.
Napp Pharmaceuticals Limited
Zentiva S.A.
Theratechnologies Inc.
GlaxoSmithKline plc
C. R. Bard, Inc.
Boehringer Ingelheim GmbH
Novartis AG
Abbott Laboratories
3M Health Care Ltd.
Pfizer Inc.
Consort Medical plc
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1314893

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed May 6, 2016
12:57:22 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

Web Address

http://www.researchandmarkets.com/reports/1314893

Office Code

SC

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 125
Electronic (PDF) - Site License USD 250
Electronic (PDF) - Enterprisewide USD 375

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email:
Job Title:
Organisation:
Address:
City:
Post/Zip Code:
Country:
Phone:
Fax:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed May 6, 2016
12:57:22 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

You will receive an email with a link to a secure page to enter your credit card details.

 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)